focus -WSS

focus

author：knowledge 2025-09-27 16:16:59 - browse：63

Senate Health, Education, Labor, and Pensions Chair Sen. Bernie Sanders, I-Vt., points toward a poster detailing what he said the U.S. versus the "Rest of the World" spends on prescription drugs, during a hearing to examine the cost of prescription drugs. -- health policy coverage — Sen. Bernie Sanders (I-Vt.) raises his hand at a Thursday hearing on Capitol Hill in Washington to examine the cost of prescription drugs. Jacquelyn Martin/AP

WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater.

The hearing, featuring Merck CEO Robert Davis, Johnson & Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared. Photographers flocked for photos as Sanders shook hands with each executive, standard practice before such hearings begin.

Sanders’ staff got an arm workout switching out foam boards behind the chairman’s head, illustrating how the drug companies called to testify make more revenue from the United States on certain medications than the rest of the world combined.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Oprah kicked off a national conversation on obesity. Let's have it

focus

WSS

Merck drug for rare lung condition set for approval in U.S.

Supreme Court mifepristone arguments center on docs' right to sue

Merck drug for rare lung condition set for approval in U.S.

VC firm General Catalyst wants to buy a health system

Histogen: Failed biotech offers rare public look inside

Analysis of telehealth claims data suggest service duplication

explore

focus

explore

Medicare proposal to cover medical devices draws a mixed reaction

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Bright Health sells Medicare Advantage business to Molina

AI can decode, harness the power of the humane immune system

Activists slam private health insurers over coverage restrictions

Covid vaccine financial winners and losers, from Pfizer to Novavax

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

When women are denied an abortion, their children fare worse than peers

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Why the world’s most expensive drug might be worth the price

hotspot

Why the world’s most expensive drug might be worth the price

Primary care physicians play key roles in Alzheimer's management

Decaf coffee targeted by food safety group under obscure FDA rule

AI can decode, harness the power of the humane immune system

Liquid biopsy for lung cancer is launched by Delfi

What to expect at HLTH 2023, the health care industry conference

hotspot

focus

focus

focus